Fierce Pharma
OCTOBER 21, 2023
Exelixis touted last month that its Cabometyx proved so successful in neuroendocrine tumors that the trial ended early. | Exelixis touted last month that its Cabometyx proved so successful in neuroendocrine tumors that the trial ended early. Now, we get to see what one analyst had already heralded as the “dramatic improvements” at the ESMO Congress.
Drug Patent Watch
OCTOBER 21, 2023
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent… The post New tentative approval for MYLAN drug sugammadex sodium appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 21, 2023
After two immunotherapies demonstrated their power against endometrial cancer, AstraZeneca now suggests that adding Merck-partnered Lynparza to its Imfinzi may offer another option. | After two immunotherapies demonstrated their power against endometrial cancer, AstraZeneca now suggests that adding Merck-partnered Lynparza to its Imfinzi may offer another option.
Drug Patent Watch
OCTOBER 21, 2023
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent… The post New tentative approval for Sandoz drug sugammadex sodium appeared first on DrugPatentWatch - Make Better Decisions.
Fierce Pharma
OCTOBER 21, 2023
Bladder cancer hasn’t been the easiest tumor type to tackle for immunotherapies. Bristol Myers Squibb has found success here with its Opdivo, but the win was overshadowed by competitor data. | Bladder cancer hasn't been the easiest tumor type to tackle for immunotherapies. Bristol Myers Squibb has found success here with its Opdivo, but the win was overshadowed by Keytruda and Padcev's competitor data.
Client Pharma
OCTOBER 21, 2023
This October, ClientPharma marked a significant milestone – our 10th anniversary! Over the past decade, we’ve dedicated ourselves to supporting the advancement of clinical research and significantly contributing to improving patients’ lives worldwide. What began as a clear vision has evolved into a thriving, caring, specialized clinical trial supply company.
Drug Patent Watch
OCTOBER 21, 2023
This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Luxembourg? appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
86 
Let's personalize your content